BioSpace News Archive

The Multiple Myeloma Research Foundation (MMRF) today announced that 34 abstracts will be presented at the 61st American Society of Hematology Annual Meeting in Orlando from December 7-10.

The 100th gathering of the American Geophysical Union Dec. 9-13 will feature dozens of staff members from the National Ecological Observatory Network who will present papers, give talks and demonstrate ways to use the growing body of information collected by the nation’s first continental-scale laboratory with data portal demos.

Gilero, a contract design, development and manufacturing firm specializing in medical and drug delivery devices, has announced the opening of a new Design Center in Carlsbad, California

Bayer today announced the publication of an analysis of the PROTECT VIII extension study in which a subset of 33 patients with hemophilia A who received five years of prophylactic treatment with Jivi® (antihemophilic factor [recombinant] PEGylated-aucl) maintained a safety and efficacy profile that was consistent with a prior analysis of the same subset, as well as with an analysis of the pivotal Phase III PROTECT VIII main study

Chubb announced today leadership appointments for North America Commercial Insurance, the company’s $5.8 billion retail commercial property and casualty (P&C) insurance division that serves middle market and small businesses through 48 offices in the United States and Canada.

Bristol-Myers Squibb Company (NYSE: BMY) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that following the late-cycle review meeting on December 4, 2019, they were notified by the U.S. Food and Drug Administration (FDA) that Reblozyl (luspatercept-aamt) will not be reviewed at the Oncologic Drugs Advisory Committee (“ODAC”) meeting scheduled for December 18, 2019.

Alpha Holdings, Inc. (KOSDAQ: 117670) (“Alpha”), the largest stockholder of OncoSec Medical Incorporated (NASDAQ: ONCS) (“OncoSec”), with an approximate 15.1% ownership stake, today filed a definitive proxy statement and sent a letter to stockholders of OncoSec opposing the proposed takeover of OncoSec by China Grand Pharmaceuticals and Healthcare Holdings (“CGP”) and Sirtex Medical US Holdings, Inc.

Harris Williams, a global investment bank specializing in M&A advisory services, announces that it advised Longs Pharmacy Solutions (Longs), a portfolio company of Tailwind Capital (Tailwind), on its sale to PharMedQuest, a portfolio company of Kinderhook Industries, LLC (Kinderhook).

The American Society of Hematology (ASH) today released the most comprehensive set of recommendations to date aimed at establishing uniformity and global standards for clinical trial endpoints used to evaluate new therapies for sickle cell disease (SCD).

Proton Therapy Partners (PTP) is pleased to announce the addition of David L. Bernd to its Board of Directors.